BioSpace News Archive

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that the European Commission has granted a conditional marketing authorization for COVID-19 Vaccine Moderna, allowing vaccination programs using the Moderna vaccine to be rolled out across the European Union.

USANA Health Sciences, Inc. (NYSE:USNA) today announced that fourth quarter results will be released after the close of market Tuesday, February 9, 2021. Shortly following the issuance of the Company’s earnings release, the Company will post a “Management Commentary, Results and Outlook” document on the Company’s website ( http://ir.usana.com ) under the “Investor Relations” section of the site. The following morning at 11

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the journal Nature Methods has selected spatially-resolved transcriptomics as their prestigious Method of the Year for 2020.

Willamette Surgery Center achieved a milestone in 2020, performing 200 total joint replacements as of November and finished the year with a record 254 total joint replacements.

SOLVD Health (www.solvdhealth.com), a privately held company focused on preventing disease by making actionable and contextual health information accessible to everyone, is preparing to launch a U.S. clinical study of its non-invasive colorectal cancer (CRC) screening test, LifeKit® Prevent.

The Lustgarten Foundation and the American Association for Cancer Research have established two new career development awards for both early-career female and under-represented pancreatic cancer researchers, representing a generous commitment of the Lustgarten Foundation of up to $1.8 million.

Noveome Biotherapeutics, Inc . , a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, today announced the publication of preclinical results evaluating the neuroprotective properties of fractionated and unfractionated ST266 in the journal PLOS ONE . The studies demonstrated that the comple

Medline and Tricol Biomedical, Inc. announced an exclusive agreement to distribute Hemostatic Control products in North America to acute care, emergency services, and cath lab providers.

The Allen Institute’s founding CEO, Allan Jones, Ph.D., announced he will step down after nearly 18 years with the organization.

iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, announced that it will participate in the 10th Annual LifeSci Partners Corporate Access Event, January 6-8 and 11-14, 2021.